News
-
-
PRESS RELEASE
Press Release: EAACI: Dupixent demonstrated superiority over Xolair (omalizumab) in chronic rhinosinusitis with nasal polyps in patients with coexisting asthma in first-ever presented phase 4 head-to-head respiratory study
Dupixent outperformed Xolair in treating chronic rhinosinusitis with nasal polyps and coexisting asthma, showing superior efficacy across all key endpoints in a phase 4 study presented at EAACI -
PRESS RELEASE
New to The Street Episode #671 Airs Tonight on Bloomberg Television at 6:30 PM EST Featuring FLOKI, Arrive AI (NASDAQ: ARAI), Health In Tech (NASDAQ: HIT), Vita Bella, and NRX Pharmaceuticals (NASDAQ: NRXP)
New to The Street premieres Episode #671 featuring dynamic companies across blockchain, AI, health tech, wellness, and pharmaceutical sectors. Sponsored by The Sustainable Green Team's Waterless Garden and PetVivo Holdings, Inc.'s SPRYNG™ product -
PRESS RELEASE
Battery X Metals Validates Provisional Patent Applications Filed with the United States Patent and Trademark Office Through Successful Real-World Trials of Next-Generation Lithium-Ion Battery Rebalancing Machine
Battery X Rebalancing Technologies achieves 100% recovery of imbalance-related capacity in Nissan Leaf & recovers 37.7% of Rated Capacity in Class 3 commercial EV battery pack. Validation trials support pending USPTO patent applications & position as EV battery reconditioning market leader -
-
-
-
PRESS RELEASE
Onco-Innovations Engages the University of Alberta and Cross Cancer Institute to Expand PNKP Inhibitor Research into Hard-to-Treat Cancers
Onco-Innovations partners with University of Alberta and Cross Cancer Institute for preclinical study focusing on hard-to-treat cancers, starting with glioblastoma. Research led by Dr. Michael Weinfeld -
-
